CLDX Operating Income Growth
Celldex Therapeutics Inc · Operating Income Growth
CLDX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.26%period ending
CLDX Quarterly Operating Income YoY % (500.00% → -26.26%)
Year-over-year change
High-resolution chart · PNG
CLDX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -26.2555% | |
| -34.5814% | |
| -55.616% | |
| -41.2289% | |
| -37.8695% | |
| -54.4991% | |
| -17.6371% | |
| -26.3998% | |
| -39.488% | |
| -25.0593% | |
| -70.7979% | |
| -48.8988% | |
| 8.7674% | |
| -39.6182% | |
| -37.0944% | |
| -33.0004% | |
| -170.8036% | |
| -39.774% | |
| 17.921% | |
| -45.1959% | |
| -18.2578% | |
| -29.3153% | |
| -90.7845% | |
| -21.0908% | |
| 7.2775% | |
| 28.2816% | |
| -7.1523% | |
| -52.5502% | |
| 27.3573% | |
| 85.0088% | |
| 52.5112% | |
| 75.7079% | |
| 41.6724% | |
| -240.8436% | |
| 26.7589% | |
| -6.5615% | |
| 10.6223% | |
| 1.6581% | |
| -4.2287% | |
| 7.3461% | |
| 1.1725% | |
| -15.2448% | |
| -4.3275% | |
| -6.6871% | |
| -14.7151% | |
| 1.6133% | |
| -44.9353% | |
| -30.3967% | |
| -53.0121% | |
| -80.9609% | |
| -33.6193% | |
| -57.7452% | |
| -38.3304% | |
| -30.9527% | |
| -153.272% | |
| -28.5154% | |
| -36.5044% | |
| -37.5854% | |
| 12.6759% | |
| -29.2713% | |
| -6.4075% | |
| -2.6682% | |
| 16.5078% | |
| -24.0777% | |
| -6.4542% | |
| -20.8138% | |
| 103.1527% | |
| 16.5771% | |
| 15.7987% | |
| 64.8898% | |
| 315.2945% | |
| -105.3493% | |
| -264.8687% | |
| -427.6284% | |
| 22.9068% | |
| 32.0207% | |
| 55.1056% | |
| -45.9669% | |
| -148.1131% | |
| -31.749% | |
| -28.9717% | |
| 42.635% | |
| 483.0732% | |
| -22.1735% | |
| -22.7983% | |
| -155.66% | |
| -31.9153% | |
| -76.1292% | |
| -24.9664% | |
| 43.6501% | |
| 19.5972% | |
| -445.283% | |
| 40.012% | |
| 31.9087% | |
| 49.6367% | |
| 93.9605% | |
| 13.4555% | |
| -9.1997% | |
| -36.4886% | |
| -52.1218% |